Cardiovascular disease (CVD), including coronary artery disease and stroke/peripheral artery disease, is less commonly reported than venous thromboembolism in subjects with antiphospholipid antibodies (aPLs) and little is known about the association of CVD with adjusted Global AntiphosPholipid Syndrome Score (aGAPSS).
The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies / Di Minno, Matteo Nicola Dario; Scalera, Antonella; Tufano, Antonella; Ambrosino, Pasquale; Bettiol, Alessandra; Silvestri, Elena; Emmi, Giacomo; Prisco, Domenico. - In: ATHEROSCLEROSIS. - ISSN 1879-1484. - ELETTRONICO. - 278:(2018), pp. 60-65. [10.1016/j.atherosclerosis.2018.09.010]
The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies
Bettiol, Alessandra;Silvestri, Elena;Emmi, Giacomo;Prisco, Domenico
2018
Abstract
Cardiovascular disease (CVD), including coronary artery disease and stroke/peripheral artery disease, is less commonly reported than venous thromboembolism in subjects with antiphospholipid antibodies (aPLs) and little is known about the association of CVD with adjusted Global AntiphosPholipid Syndrome Score (aGAPSS).
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
